2022³âµµ ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ Ãß°èÇмú´ëȸ [1ÀÏÂ÷] : 2022-10-07±³À°ÀÏÀÚ : 2022-10-07
±³À°Àå¼Ò : ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ
±³À°ÁÖÁ¦ :
2022³âµµ ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ Ãß°èÇмú´ëȸ [1ÀÏÂ÷]ÁÖÃÖ±â°ü : ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ
´ã´çÀÚ : ÀÓ´Ù½½
¿¬¶ôó : 02-537-6171
À̸ÞÀÏ :
knpa3355@hanmail.net ±³À°Á¾·ù : Á¤½Å°Ç°ÀÇÇаú
Âü¼®¿¹»óÀοø : 600¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
±¤ÁÖ±¤¿ª½Ã±³À°½Ã°£ : 35 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 160,000¿ø
ºñ°í - »çÀüµî·Ï: Á¤È¸¿ø 120,000 / ÀϹÝȸ¿ø(Àü°øÀÇ) 70,000 / Á¤½Å°Ç°°ü·Ã ±Ù¹«ÀÚ¡¤´ëÇлý¡¤´ëÇпø»ý 70,000 / ÀϹÝ(Ÿ°ú ¼Ò¼Ó) 140,000 - ÇöÀåµî·Ï: Á¤È¸¿ø 140,000 / ÀϹÝȸ¿ø(Àü°øÀÇ) 90,000 / Á¤½Å°Ç°°ü·Ã ±Ù¹«ÀÚ¡¤´ëÇлý¡¤´ëÇпø»ý 90,000 / ÀϹÝ(Ÿ°ú ¼Ò¼Ó) 160,000 *Äڷγª¹ÙÀÌ·¯½º »óȲ¿¡ µû¶ó ÇöÀåµî·ÏÀÌ ÁøÇàµÇÁö ¾ÊÀ» ¼ö ÀÖ½À´Ï´Ù.
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ1 09:00~09:30 Á¤½Å°ú ÀǷẸÇè ¼ö°¡ º¯È À̺´Ã¶(ÇѸ²ÀÇ´ë, ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ º¸ÇèÀÌ»ç)
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ1 09:30~10:00 Á¤½Å°Ç°º¹Áö¹ý °³Á¤¹æÇâ ÀÌÈ¿µ(¼øõÇâÀÇ´ë, ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ ¹ýÁ¦ÀÌ»ç)
Åä·Ð 10-07 ÄÁº¥¼ÇȦ1 10:00~10:10 ÁúÀÇ ¹× Åä·Ð 1 ¹éÁ¾¿ì(°æÈñÀÇ´ë, ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ ¹ý»çÀ§¿øȸ À§¿øÀå)
Åä·Ð 10-07 ÄÁº¥¼ÇȦ1 10:10~10:20 ÁúÀÇ ¹× Åä·Ð 2 ¼®Á¤È£(¿¬¼¼ÀÇ´ë, ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ º¸ÇèÀ§¿øȸ À§¿øÀå)
Åä·Ð 10-07 ÄÁº¥¼ÇȦ1 10:20~10:30 Àüü Åä·Ð ()
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ2 09:00~09:20 Sound/ultrasound gamma entrainment therapy ±èÅÂ(GIST ÀÇ»ý¸í°øÇаú)
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ2 09:20~09:40 Flickering light stimulation for entraining gamma waves ¹Ú¿¹½Â(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ2 09:40~10:00 Transcranial direct current stimulation for cognitive disorders °µ¿¿ì(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ2 10:00~10:20 Biophotonic technologies for brain stimulation ±èÀç°ü(GIST ÀÇ»ý¸í°øÇаú)
Åä·Ð 10-07 ÄÁº¥¼ÇȦ2 10:20~10:30 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ3 09:00~09:20 The effect of COVID-19 pandemic on sleep disturbance and circadian rhythm ³ëÇö¿õ(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ3 09:20~09:40 Long COVID-19 and the importance of mental health À̼ö¿µ(¸íÁöº´¿ø)
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ3 09:40~10:00 How sleep interacts with the immune system ±è¿ìÁ¤(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ3 10:00~10:20 Lessons from the COVID-19 and future direction in psychiatry Á¶Ã¶Çö(Ãæ³²ÀÇ´ë)
Åä·Ð 10-07 ÄÁº¥¼ÇȦ3 10:20~10:30 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 10-07 208-210È£ 09:00~09:20 ¹«¾ùÀ» °¡¸£Ä¥ °ÍÀΰ¡? - ÀÎÁöÇൿġ·á ¼ö·Ã ¸ñÇ¥¿Í ÇÙ½É ¿ª·® ¹éÁöÇö(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 10-07 208-210È£ 09:20~09:40 ¾î¶»°Ô °¡¸£Ä¥ °ÍÀΰ¡? - ÀÎÁöÇൿġ·á ¼ö·Ã¿¡¼ÀÇ Çǵå¹é°ú Áöµµ°¨µ¶ ÀÌö¼ø(°æ»óÀÇ´ë)
±³À°½Ã°£ 10-07 208-210È£ 09:40~10:00 ¾îµð¼ºÎÅÍ ½ÃÀÛÇÒ °ÍÀΰ¡? - Àü°øÀÇ ÀÎÁöÇൿġ·á ±³À° ¹× Áöµµ ÇöȲ ³ªÀÇÇö(¿¹¼öº´¿ø)
±³À°½Ã°£ 10-07 208-210È£ 10:00~10:20 ¾îµð·Î ³ª¾Æ°¥ °ÍÀΰ¡? - ÀÎÁöÇൿġ·á ¼ö·Ã ¹æÇâ¿¡ ´ëÇÑ Á¦¾ð ±èÁö¼±(¼øõÇâÀÇ´ë)
Åä·Ð 10-07 208-210È£ 10:20~10:30 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 10-07 212-213È£ 09:00~09:20 À¶ÀÇ ½É¸®ÇÐÀû À¯Çü·Ð: °Ë»çµµ±¸ÀÇ À¯¿ë¼º°ú ÇÑ°è ½Å¿ë¿í(¿ï»êÀÇ´ë)
±³À°½Ã°£ 10-07 212-213È£ 09:20~09:40 ½É¸®µµ½Ä À̷п¡ µû¸¥ À¯Çüº° µðÁöÅÐ ¸àÅ»Äɾî ÇÁ·Î±×·¥ – ¸¶Àε鸵 ¹®¿ì¸®(Æ÷ƼÆÄÀÌ ´ëÇ¥)
±³À°½Ã°£ 10-07 212-213È£ 09:40~10:00 À¶ÀÇ ½É¸®ÇÐÀû À¯Çü·ÐÀÇ º»Áú°ú ½Ì¾î·ç¹Ì½º °Ë»çÀÇ Æ¯¼º ¹ÚÈ¿ÀÎ(À¶ÇÐÆĺм®°¡¹ÚÈ¿ÀÎ)
±³À°½Ã°£ 10-07 212-213È£ 10:00~10:20 MBTIÀÇ ¹ßÀü°úÁ¤°ú È°¿ëÇöȲ ±èÁ¤ÅÃ(¼°´ëÇб³ ½É¸®Çаú ¸í¿¹±³¼ö, ¿¹¼öȸ ¿µ¼º½É¸®»ó´ã¼Ò ¼ÒÀå)
Åä·Ð 10-07 212-213È£ 10:20~10:30 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 10-07 214È£ 09:00~09:20 »çȸÇÐÀû °üÁ¡¿¡¼ÀÇ Á¤½Å°Ç°°ú ¿©¼º À̹ξÆ(Áß¾Ó´ëÇб³ »çȸÇаú)
±³À°½Ã°£ 10-07 214È£ 09:20~09:40 10´ë û¼Ò³â ¿©¼º¿¡¼ÀÇ ÀÚÇØ¿Í ÀÚ»ì ÇöȲ°ú °³ÀÔ ÀÌ¿¬Á¤(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 10-07 214È£ 09:40~10:00 20-30´ë ¿©¼º¿¡¼ÀÇ °íÀ§Çè À½ÁÖÀÇ ¹®Á¦Á¡°ú ´ëó À̽¿±(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 10-07 214È£ 10:00~10:20 ¿©¼º¿¡¼ »ý¾ÖÁֱ⿡ µû¸¥ ¼ö¸éÀÇ Æ¯Â¡ ¹× ¼ö¸éÀå¾Ö ¾È¼ÒÇö(Ãæ³²ÀÇ´ë)
Åä·Ð 10-07 214È£ 10:20~10:30 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ1 10:40~11:20 ¡°Á¤½ÅÀû »óóÀÇ ´ë¹°¸²À» ¿°·ÁÇÏ´Â 40´ë ¿©¼º¡± »ç·Ê ¹Ú¿µ·Ï(¿ÂÁ¤½Å°Ç°ÀÇÇаúÀÇ¿ø, Çѱ¹ºÐ¼®½É¸®ÇÐȸ)
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ1 11:20~11:40 Çѱ¹Á¤½ÅÄ¡·áÇÐȸ °üÁ¡¿¡¼ÀÇ Åä·Ð À̹üÁ¤(À̹üÁ¤Á¤½Å°Ç°ÀÇÇаúÀÇ¿ø, Çѱ¹Á¤½ÅÄ¡·áÇÐȸ)
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ1 11:40~12:00 ¼ºÀÎÀÇ ¹ß´Þ°ú Á¤½ÅºÐ¼®Àû °üÁ¡¿¡¼ÀÇ Åä·Ð ÀÌÁ¦Á¤(±¹¸³°øÁÖº´¿ø, ´ëÇѺм®Ä¡·áÇÐȸ)
Åä·Ð 10-07 ÄÁº¥¼ÇȦ1 12:00~12:10 Àüü Åä·Ð ()
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ2 10:40~11:00 ºÒ¸éÁõÀÇ »ý¹°ÇÐÀû Ç¥ÁöÀÚ ¾öÀ¯Çö(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ2 11:00~11:20 ÀÏÁֱ⸮µë Àå¾Ö·Î¼ÀÇ ºÒ¸éÁõ ±è¼ºÀç(Á¶¼±ÀÇ´ë)
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ2 11:20~11:40 ºÒ¸éÁõÀÇ ¿øÀÎÀÌ µÇ´Â ¼ö¸éÀå¾Ö: °¨º°°ú Áø´Ü È«½Âö(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ2 11:40~12:00 ºÒ¸éÁõÀÇ ÃֽŠ¾à¹°Ä¡·á ¾È¼ÒÇö(Ãæ³²ÀÇ´ë)
Åä·Ð 10-07 ÄÁº¥¼ÇȦ2 12:00~12:10 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ3 10:40~11:00 Identifying GAD from other psychiatric condition including MDD ÀåÁø±¸(¸íÁöº´¿ø)
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ3 11:00~11:20 Diagnostic validity of biomarkers for GAD ±è¹Î°æ(Â÷ÀÇ°úÇдë)
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ3 11:20~11:40 Pharmacotherapy for GAD ¼ÁØÈ£(¿¬¼¼¿øÁÖÀÇ´ë)
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ3 11:40~12:00 Cognitive-behavioral intervention for GAD Á¶¼ºÁØ(¼º±Õ°üÀÇ´ë)
Åä·Ð 10-07 ÄÁº¥¼ÇȦ3 12:00~12:10 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 10-07 208-210È£ 10:40~11:00 Mismatch Negativity ERP ¼Ò°³ ¹× ÀÓ»óÀû È°¿ë ±èÁö¼±(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 10-07 208-210È£ 11:00~11:20 Event related potentials in depression ¹Ú¿µ¹Î(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 10-07 208-210È£ 11:20~11:40 New insights into ERP indices of performance monitoring and clinical implication ³ë´ë¿µ(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 10-07 208-210È£ 11:40~12:00 Á¤·®³úÆÄÀÇ ÀÌÇØ¿Í ÀÀ¿ë ¹ÚÁø¿µ(¿¬¼¼ÀÇ´ë)
Åä·Ð 10-07 208-210È£ 12:00~12:10 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 10-07 212-213È£ 10:40~11:05 ¿ì¿ïÁõ ºÐ¼®½É»çÀÇ ¹æÇâ ÀÌÁ¤¹Î(°Ç°º¸Çè½É»çÆò°¡¿ø ºÐ¼®½É»ç°³¹ßºÎ)
±³À°½Ã°£ 10-07 212-213È£ 11:05~11:30 Á¤½Å°Ç°ÀÇÇаúÀÇ ÀûÁ¤¼º Æò°¡(¿ì¿ïÁõ ÀûÁ¤¼º Æò°¡¸¦ Áß½ÉÀ¸·Î) ÃÖÁ¤³²(°Ç°º¸Çè½É»çÆò°¡¿ø Æò°¡½Ç)
±³À°½Ã°£ 10-07 212-213È£ 11:30~11:55 Á¤½Å°Ç°ÀÇÇаúÀÇ ¼ö°¡ °³¹ß ÇöȲ°ú ¹æÇâ ¼ÕÁöÈÆ(¼¿ïÀÇ´ë, ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ º¸ÇèÀÌ»ç)
Åä·Ð 10-07 212-213È£ 11:55~12:10 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 10-07 214È£ 10:40~11:05 º´¿øÇü Wee ¼¾ÅÍ È²ÁØ¿ø(°¿øÀÇ´ë)
±³À°½Ã°£ 10-07 214È£ 11:05~11:30 Á¤½Å°Ç°Àü¹®°¡ Çб³¹æ¹®»ç¾÷ ±èÇöÁø(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 10-07 214È£ 11:30~11:55 Á¤½Å°úÀÇ»ç Çб³ À§±â»óȲ ÀÚ¹®È°µ¿ ¾ç¼öÁø(±¤ÁÖ½º¸¶Àϼ¾ÅÍ)
Åä·Ð 10-07 214È£ 11:55~12:10 Åä·Ð ¼¿Ï¼®(¿µ³²ÀÇ´ë)
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ1 12:20~12:45 ADHD in Korea ¹Ú¹ÎÇö(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ1 12:45~13:10 Methylphenidate for the treatment of ADHD ±èÈ¿¿ø(¿ï»êÀÇ´ë)
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ2 12:20~12:45 tDCSÀÇ µÎ³ú»ý¸®¿¡ÀÇ ¿µÇâ À̽Âȯ(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ2 12:45~13:10 ¿ì¿ïÁõ¿¡¼ÀÇ tDCSÀÇ ÀÓ»óÈ¿°ú °í¿µÈÆ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ3 12:20~12:45 COVID-19 Era: Optimal treatment strategy for functional recovery in MDD patients Á¶Ã¶Çö(°í·ÁÀÇ´ë)
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ3 12:45~13:10 Clinical outcomes of anti-depressant therapy in Korean MDD patients: Efficacy & safety data of Desvenlafaxine ¹Ú¼±Ã¶(ÇѾçÀÇ´ë)
±³À°½Ã°£ 10-07 208-210È£ 13:00~13:50 Á¤½Å°Ç°ÀÇÇаú Àü°øÀÇ ¿¬Â÷º° ¼ö·Ã¸ñÇ¥ ¹× ¼ö·Ã±³°ú°úÁ¤ ±èÅÂÈñ(¿øÁÖÀÇ´ë, ¼ö·Ã°£»ç)
±³À°½Ã°£ 10-07 208-210È£ 13:50~14:40 Á¤½Å°Ç°ÀÇÇаú ¼ö·Ã±ÔÁ¤ ¹× ¼ö·Ã½ÇŽɻç±âÁØ °Àç¸í(°¡ÃµÀÇ´ë, ¼ö·Ã°£»ç)
±³À°½Ã°£ 10-07 208-210È£ 14:50~15:40 Á¤½Å°Ç°ÀÇÇаú ¼ö·Ã±³À° ¹ßÀüÀ» À§ÇÑ °í½ÃÁ¦µµ ±è¼º¿Ï(Àü³²ÀÇ´ë, °í½ÃÀÌ»ç)
±³À°½Ã°£ 10-07 208-210È£ 15:40~16:30 ¿Â¶óÀÎ Àü°øÀÇ ±³À°½Ã½ºÅÛ È°¿ë¾È³» Àü¸í¿í(±¹¸³Áß¾ÓÀÇ·á¿ø, ¼ö·Ã°£»ç)
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ1 14:00~14:50 ¹ß´Þ°ú ¼º¼÷¿¡ ´ëÇÑ Á¤½ÅºÐ¼®Àû ÀÌÇØ Á¤¼±ÁÖ(Á¤¼±ÁÖ Á¤½Å°Ç°ÀÇÇаúÀÇ¿ø)
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ2 14:00~14:20 Blood-based Biomarker in Dementia ¿Õ¼º¹Î(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ2 14:20~14:40 Blood-based Biomarker in Autism ±èÀϺó(ÇѾçÀÇ´ë)
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ2 14:40~15:00 Wearable Device-based Biomarker in Anxiety ¿ÀÁÖ¿µ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ2 15:00~15:20 Neuroimaging-based Biomarker in Suicide ÇѱԸ¸(°í·ÁÀÇ´ë)
Åä·Ð 10-07 ÄÁº¥¼ÇȦ2 15:20~15:30 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ3 14:00~14:25 ´ëÇѹα¹ ¸¶¾à·ù ½ÇÅÂÁ¶»ç À̽¿±(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ3 14:25~14:50 ±¹¿Ü ¸¶¸®È³ª ÇÕ¹ýÈ°¡ ¿ì¸®¿¡°Ô ÁÖ´Â ÇÔÀÇ ÇÑâ¿ì(¸íÁöº´¿ø)
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ3 14:50~15:15 ¸¶¾à·ù Ä¡·á Áö¿ø Á¾ÇÕ ´ëÃ¥ Àå¿ÁÁø(±¹¸³ºÎ°îº´¿ø)
Åä·Ð 10-07 ÄÁº¥¼ÇȦ3 15:15~15:30 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 10-07 212-213È£ 14:00~14:20 Á¤½ÅÀÇÇÐÀÇ ¹Ì·¡: Áø´Ü, Ä¡·á¿¡¼ °ü¸®±îÁö ±è¼öÁø(Ä«Ä«¿ÀÇコÄɾî)
±³À°½Ã°£ 10-07 212-213È£ 14:20~14:40 µ¥ÀÌÅÍ ±â¹Ý Á¤½ÅÁúȯÀÇ Æò°¡: ½º¸¶Æ®Æù ¼¾½Ì ¹× µðÁöÅÐ Æä³ëŸÀÔ ±èÇý¿ø(ÇѾçÀÇ´ë)
±³À°½Ã°£ 10-07 212-213È£ 14:40~15:00 Çѱ¹Çü ôµµÀÇ °³¹ß ¹× ÀÇÀÇ ¹ÚÁÖ¾ð(°è¿äº´¿ø)
±³À°½Ã°£ 10-07 212-213È£ 15:00~15:20 µðÁöÅÐ Ä¡·áÁ¦¿Í Á¤½ÅÀÇÇÐÀÇ ¹Ì·¡ (꺿¿¡¼ÀÇ Á¤½Å°ú ôµµ È°¿ë) ±èÀϺó(ÇѾçÀÇ´ë)
Åä·Ð 10-07 212-213È£ 15:20~15:30 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 10-07 214È£ 14:00~14:20 Distinct roles of transcranial electric stimulation for mood and anxiety disorder ¿ÀÁöÈÆ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 10-07 214È£ 14:20~14:40 Global home digital drug commercialization trend and future prospects as a medical technology À̱â¿ø(¿ÍÀ̺극ÀÎ)
±³À°½Ã°£ 10-07 214È£ 14:40~15:00 Prevention and Treatment of Alzheimer °µ¿¿ì(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 10-07 214È£ 15:00~15:20 A multimodal approach for determining tDCS therapeutic strategy for dementia ±èµ¿Çö(´º·ÎÇÍ)
Åä·Ð 10-07 214È£ 15:20~15:30 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ1 15:40~16:30 Machine learning and mathematical modeling for psychiatry ±èÀç°æ(IBS Biomedical Mathematics Group/ KAIST Mathematical Sciences)
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ2 15:40~16:05 The Evolving Concept of Digital Therapy and Its Development for AD: Targeting the ABCs of AD ¿Õ¼º¹Î(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ2 16:05~16:30 Integration of Music to Gamified Digital Therapy for AD ¼ÛÀº¼º(GIST)
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ2 16:30~16:55 How Gamification Supports People: A Case Study for Children with Developmental Disabilities È«ÁøÇõ(GIST)
Åä·Ð 10-07 ÄÁº¥¼ÇȦ2 16:55~17:10 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 10-07 212-213È£ 15:40~16:00 Effects of drug therapy as an early intervention in psychotic disorders À̺´´ë(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 10-07 212-213È£ 16:00~16:20 Molecular biological association between bipolar disorder and obesity ÀÌÁ¤±¸(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 10-07 212-213È£ 16:20~16:40 Potential biomarkers for bipolar disorder Àå¼¼Çå(ºÀ»ýº´¿ø)
±³À°½Ã°£ 10-07 212-213È£ 16:40~17:00 Sleep disturbance in dementia ¹æ¿µ·Õ(¿ï»êÀÇ´ë)
Åä·Ð 10-07 212-213È£ 17:00~17:10 ÁúÀÇ ÀÀ´ä ()
±âŸ 10-07 214È£ 15:40~16:00 Çѱ¹ÀÇ ³¹Î ÇöȲ°ú ³¹Î¹ý ÀÌŹ°Ç(À¯¿£³¹Î±â±¸)
±âŸ 10-07 214È£ 16:00~16:20 ÀÌÁֹΰú ³¹ÎÀÇ Á¤½Å°Ç°°ú Àڻ쿹¹æ ±è¹Ì¼±(Çѱ¹ÀÌÁֹΰǰÇùȸ Èñ¸ÁÀÇÄ£±¸µé »óÀÓÀÌ»ç)
±âŸ 10-07 214È£ 16:20~16:40 ij³ª´ÙÀÇ »ç·Ê¸¦ ÅëÇØ º» ÀÌÁֹΰú ³¹Î µ¹º½ÀÇ ³²Àº °úÁ¦¿Í ¹æÇâ ÀÌÀçÇå(ij³ª´Ù ¿þ½ºÅÏ´ëÇб³ ½¶¸¯ÀÇ´ë Á¤½Å°Ç°ÀÇÇаú)
±âŸ 10-07 214È£ 16:40~17:00 ³¸¼± ¹®È¿¡¼ ¿Â »ç¶÷°úÀÇ °ø°¨°ú Ä¡À¯ Á¤Âù½Â(¸¶À½µå¸²ÀÇ¿ø)
Åä·Ð 10-07 214È£ 17:00~17:10 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 10-07 ÄÁº¥¼ÇȦ1+2 17:30~18:20 Á¤½Å°Ç°ÀÇÇаú Áø·á½ÇÀÇ ´Ü»ó ÁöÇö½Â(Ãæ³²ÀÇ´ë)